Bio-Rad reported $598.2 million in revenues for the quarter, down from $602.6 million a year ago but surpassing the average analysts' estimate of $593.4 million.
The firm has also created a qPCR-based Staphylococcus aureus resistance gene assay with a run time of three minutes.
Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.
The company is offering about 2.7 million units consisting of preferred stock and warrants at $8.80 per unit.
Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.
In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.
Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.
The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.
The House of Lords in the UK approves a bill to allow mitochondrial donation.